OS for real-world patients with R/R PTCL and CTCL receiving combination duv/romi. Kaplan-Meier curves show OS estimates since duv/romi treatment initiation. (A) Comparison by best response (CR + PR) vs best response: progression (PD + SD) on duv/romi with standard censoring. (B) Comparison by best response (CR + PR) vs best response: progression (PD + SD) on duv/romi and allo-HSCT censored. P values calculated by log-rank test. PR, partial response; SD, stable disease.